<DOC>
	<DOCNO>NCT02575625</DOCNO>
	<brief_summary>Hypothesis study existence relation parameter measure FibroScan® FS 502 accord non invasive method liver steatosis condition . This proof concept validation make two step : - Step 1 : feasibility study method 10 healthy volunteer - Step 2 : diagnosis study 50 healthy volunteer ( 25 18-30 years-old 25 40-65 years-old ) 25 patient care include liver biopsy et histological answer clean steatosis ( NAFLD ) . Experimental procedure consist : - Fibroscan measure , precede track ultrasonography . - liver MRI ( substudy MRI comparison , step 2 ) - blood test biological assessment liver function</brief_summary>
	<brief_title>Fibroscan® Medical Device , Assessment Non Invasive Diagnosis Liver Steatosis</brief_title>
	<detailed_description>Diagnosis liver lipid overload ( name liver steatosis ) , unrelated alcohol consumption , still mainly base histological exam liver . An histological continuity exist go clean liver steatosis ( Non Alcoholic Fatty Liver Disease , NAFLD ) steatohepatitis sign inflammation tissue fibrosis ( Non Alcoholic Steato-Hepatitis , NASH ) . It 's well-known disease evolve cirrhosis complication . Hypothesis study existence relation parameter measure FibroScan® FS 502 accord non invasive method liver steatosis condition . This proof concept validation make two step : - Step 1 : feasibility study method 10 healthy volunteer - Step 2 : diagnosis study 50 healthy volunteer ( 25 18-30 years-old 25 40-65 years-old ) 25 patient care include liver biopsy et histological answer clean steatosis ( NAFLD ) . Measures healthy volunteer enable intra-operator reproductibility analysis , study age effect search potential mechanic age liver . Experimental procedure consist : - Fibroscan measure , precede track ultrasonography . - liver MRI ( substudy MRI comparison , step 2 ) - blood test biological assessment liver function The final aim study propose device enable medical community vivo hepatic rheology observation , highly correlate liver lipid overload . After industrialization innovation , diffusion could make easy patient follow-up .</detailed_description>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Healthy subject Steps 1 2 Age 18 65 year old ( 2 age group step 2 : 1830 et 4065 yearsold ) Written inform consent form sign Affiliated medical insurance Alcohol consumption d'alcool &lt; 20g/j woman , &lt; 30g/j men Patients liver steatosis Step 2 More 18 year old Written inform consent form sign Affiliated medical insurance Patients clean steatosis confirm histological result liver biopsy do previous month Alcohol consumption d'alcool &lt; 20g/j woman , &lt; 30g/j men Healthy subject Step 1 Exposure chemical poison ( solvent , paint , drug ) previous 4 week Pregnant woman , lactate woman , woman age procreation without reliable contraception Presence ascites Person guardianship Healthy subject Step 2 Exposure chemical poison ( solvent , paint , drug ) previous 4 week Pregnant woman , lactate woman , woman age procreation without reliable contraception Contraindication MRI Presence ascites Person guardianship Healthy subject Steps 1 2 Presence liver tumor ascites ( diagnose MRI ultrasonography ) Abnormal liver function test ( increase transaminase , gammaGT ) Patients liver steatosis Step 2 Exposure chemical poison ( solvent , paint , drug ) previous 4 week Pregnant woman , lactate woman , woman age procreation without reliable contraception Contraindication MRI Presence ascites liver tumor Serology anti VHC+ Ag HBs+ Infection HIV Autoimmun hepatitis Genetic hemochromatosis , Wilson disease , lake alpha1antitrypsin Fibrosis liver cirrhosis biopsy Person guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Liver steatosis</keyword>
	<keyword>Steatohepatitis</keyword>
	<keyword>Fibroscan</keyword>
</DOC>